Operator
Greetings, and welcome to Global Blood Therapeutics' conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut. Please go ahead, sir.
Steven Immergut --
Investor Relations
Thank you, and welcome to GBT's conference call to discuss the company's financial results for the second-quarter 2021 and to provide a business update. I'm Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, will provide an update on our progress in the second quarter; Jeff Farrow, our chief financial officer, will review our financial results; David Johnson, or DJ, our chief commercial officer, will give an update on the Oxbryta launch; Dr.